Skip to main content
Equibles

STOREBRAND ASSET MANAGEMENT AS

Position in RPRX — Royalty Pharma plc

CIK 1685676 LYSAKER, Q8
Back to RPRX Full portfolio

Position in RPRX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$39,471,149
+$2,215,633 QoQ
Shares Held
703,962
-9.4% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#70
of 646 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STOREBRAND ASSET MANAGEMENT AS holds $199,901,062 across 11 Biotechnology names. RPRX ranks #2 (19.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 107,628 $53,462,056
2 RPRX
Royalty Pharma plc
This page 		703,962 $39,471,149
3 JAZZ
Jazz Pharmaceuticals plc
 109,183 $26,309,827
4 REGN
Regeneron Pharmaceuticals, Inc.
 38,479 $23,993,195
5 ALNY
Alnylam Pharmaceuticals, Inc.
 57,580 $17,333,307
6 RVMD
Revolution Medicines, Inc.
 80,251 $15,029,407
7 INSM
INSMED Inc
 124,848 $13,311,293
8 INCY
Incyte Corp
 78,878 $8,941,610

All Filings in RPRX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $39,471,149 703,962
2026-03-31 $37,255,516 776,642
2025-12-31 $31,457,480 814,117
2025-09-30 $32,166,293 911,743
2025-06-30 $22,839,128 633,892
2025-03-31 $19,757,183 634,667
2024-12-31 $20,379,709 798,891
2024-09-30 $12,454,050 440,228
2024-06-30 $12,017,520 455,727
2024-03-31 $13,135,450 432,514
2023-12-31 $8,225,032 292,810
2023-09-30 $7,468,738 275,193
2023-06-30 $9,948,355 323,629
2023-03-31 $13,468,914 373,825
2022-12-31 $8,715,227 220,527
2022-09-30 $1,223,119 30,441
2022-06-30 $1,196,080 28,451
2022-03-31 $931,144 23,900
2021-12-31 $897,501 22,522
2021-09-30 $505,598 13,990
2021-06-30 $218,066 5,320
2021-03-31 $232,058 5,320